SEBULSKY ALAN bought PBLS

June 15, 2026 · Form 4 insider transaction

SEBULSKY ALAN bought 5,000 shares of Parabilis Medicines, Inc. at $26.00 per share, a transaction worth $130.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
5,000
Price
$26.00
Total value
$130.0K
RoleDirector
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJune 15, 2026
Filing dateJune 16, 2026
Shares owned after25,935
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.61 to $26.25, inclusive.; Represents shares held by Apothecary Capital LLC ("Apothecary Capital"). The Reporting Person is the managing member of Apothecary Capital and may be deemed to share voting, investment and dispositive power with respect to the securities held by Apothecary Capital. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.

View the original Form 4 on SEC EDGAR